Celmatix was recognized for its innovation in fertility prediction as one of Fast Company’s Top 50 World’s Most Innovative Companies. Celmatix is a biotech company spun out of Weill Cornell that leverages predictive analytics and genomics to create products focused on the treatment of infertility and proactive fertility management.